Abstract
Abstract
Background
The use of stimulants and other substances with the purpose of enhancing, maintaining, and prolonging sexual activity is known as sexualized substance use. Also known as chemsex, this pattern of use has been mainly explored in high-income countries. The aim of this article was to assess the feasibility, acceptability, and usefulness of a community- evidence-based harm reduction intervention among Mexican gay, bisexual, and other men who have sex with men (gbMSM) adults who reported sexualized stimulant use in the past 6 months and who were not enrolled in any psychosocial treatment.
Methods
The in-person intervention was designed in partnership with gbMSM who used substances. It consisted of 39 harm reduction strategies before, during, and after episodes of use. The components of the intervention were health and self-care, safety, and psychopharmacology. The intervention was delivered at a university campus, a public recreational space, and an HIV public clinic. Feasibility to deliver the intervention was assessed based on enrolment and completion rates; acceptability through a 28-item, 5-point Likert scale (140 max.) constructed and validated for the Mexican population with good reliability coefficients; usefulness through a 5-point Likert scale (“not useful”-“very useful”) for each of the 39 strategies; and potential behavioral change by subtracting the likelihood of implementing each strategy minus the frequency of use of the technique before the intervention.
Results
Participants (n = 19; recruitment rate = 35.2%; completion rate = 84.2%) rated the intervention as acceptable with a mean score of 121.6 (SD = 7.5). The highest potential for behavioral change was regarding the use of information about the half-life of stimulants, polysubstance use, and overdose prevention.
Conclusions
This intervention is feasible when provided within public health services where potential participants are already in contact. Harm reduction strategies need to surpass sexually transmitted infections prevention and HIV care and focus on substance use and mental health strategies.
Funder
Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica
Publisher
Springer Science and Business Media LLC
Reference70 articles.
1. UNODC. World drug report 2023. United Nations (2023).
2. Brouwer KC, Case P, Ramos R, Magis-Rodríguez C, Bucardo J, Patterson TL, Strathdee SA. Trends in production, trafficking, and consumption of methamphetamine and Cocaine in Mexico. Subst Use Misuse. 2006;41(5):707–27. https://doi.org/10.1080/10826080500411478.
3. Maldonado Aranda S. Drogas, violencia y militarización en el México rural. El caso de Michoacán. Rev Mex Sociol. 2012;74(1):5–39.
4. UNODC. Primary drug of use among persons treated for drug problems 2014–2019 (or latest year available). World Drug Report 2021 (2023). Retrieved from https://www.unodc.org/res/WDR-2023/annex/5.1_Treatment_by_primary_drug_of_use.xlsx
5. CONADIC. Demanda de tratamiento por consumo de sustancias psicoactivas en 2021. In: Observatorio Mexicano de Salud Mental y Consumo de Drogas (2022).